Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Website Related Posts 5 Small-cap Biotech ETFs to Watch May 21, 2025 Metals Focus: PGMs Deficits Deepen as Supply Tightens and Demand Realigns May 21, 2025 Regulator: New York Taking Strong Steps in Bid to Become World’s “Crypto Capital” May 21, 2025